<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Clopidogrel and Side Effects

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2001 English Publisher:S. Karger AGJournal:Cardiology, volume 96, pages 51-52 (issn: 0008-6312, eissn: 1421-9751,

Authors: H. Wirtz; F. Reichenberger; R. Paschke;

doi: 10.1159/000047386

pmid: 11701941

Clopidogrel and Side Effects

- Summary
- Subjects
- Metrics

Abstract

Clopidogrel is a recently developed thrombocyte inhibitor with fewer side effects. We report 2 patients with purpura and thrombopenia, respectively, due to clopidogrel therapy. As this compound is widely used in clinical practice, the occurrence of hematological and dermal side effects should be considered.

Related Organizations

University Hospital Leipzig
Germany
Leipzig University
Germany

Keywords

Aged, 80 and over, Ticlopidine, Purpura, Thrombotic Thrombocytopenic, Humans, Female, Platelet Aggregation Inhibitors, Aged, Clopidogrel

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%